Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed attachment file name title grouped question UIN question first answered answering member label
tabling member	label

Search

750552

registered interest
date	11/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	General Practitioners
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government what assessment they have made of the chronic fatigue syndrome myalgic encephalomyelitis (ME/CFS) clinical services which were set up between 2004 and 2006; what proportion of patients accessing services recover from ME/CFS or show signs of improvement; and what assessment they have made of the value for money of these services.
tabling member printed	The Countess of Mar
uin	HL684
answer	answer is ministerial correction date of answer 19/07/2017 answer text <p>No central assessment has been made of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) clinical services established between 2004 and 2006. The commissioning of services for people with CFS/ME is a local matter, and the management of patients within such services is the responsibility of the commissioners, providers and clinicians responsible for their care. Clinical commissioning groups have a duty to exercise their functions effectively, efficiently and economically</p><p> </p><p>Since its publication in 2007, the National Institute for Health and Care Excellence (NICE) clinical guideline on the management of CFS/ME in adults and children, which set outs best practice on the care, treatment and support of people with the condition, has supported the local National Health Service in delivering services for people with the condition. The guidance recognises the challenges in managing a condition for which there is no definitive diagnostic test, no clear understanding of the causes and process of disease and no cure. The guidance is also clear that there is no one form of treatment to suit every patient and that treatment and care should take into account the personal needs and preferences of the patient. NICE is currently reviewing the guidance to ensure it reflects the latest available evidence and a decision regarding this matter is expected shortly.</p><p><br></p> answering member printed Lord O'Shaughnessy question first answered 19/07/2017 11:03:01 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1861 label Biography information for The Countess of Mar

750553

registered interest
date	11/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	General Practitioners
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government whether they have any plans to set up an independent review of ME/CFS services which includes an epidemiological study to establish the true incidence of ME/CFS in the population and the impact of the shortage of doctors trained in this specialism; and, if not, why not.
tabling member printed	The Countess of Mar
uin	HL685
answer	answer is ministerial correction date of answer 19/07/2017 answer text <p>There are no plans to set up an independent review of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) services. Services for patients with CFS/ME are supported by independent, evidence-based guidance produced by the National Institute for Health and Care Excellence on the diagnosis, treatment and support of patients with the condition. Commissioners should deliver services that meet the needs of local popuations. Assessments of service need for CFS/ME may be supported by the available population prevalence estimates as required.</p> answering member printed Lord O'Shaughnessy question first answered 19/07/2017 15:08:32 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1861 label Biography information for The Countess of Mar

749951

registered interest
date	10/07/2017
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	NHS: Listed Buildings
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government whether the Health and Safety Executive will send a representative to the International Aircraft Cabin Air Conference at Imperial College, London in September; and if not, why not.
tabling member printed	The Countess of Mar
uin	HL636
answer	answer is ministerial correction date of answer 18/07/2017 answer text <p>The Health and Safety Executive (HSE) will not be attending the International Aircraft Cabin Air Conference at Imperial College, London in September 2017. HSE works with the Civil Aviation Authority (CAA) to regulate health and safety at work in the aviation industry. This operates through a memorandum of understanding and associated guidance document CAP 1484 (see documents attached).</p><p>CAP 1484 states that by agreement CAA regulates health and safety on board aircraft and advises on the health implications of exposure to hazardous substances on crew and passengers. CAA is the most appropriate regulatory attendee and HSE will seek information and updates on such issues through its regular contacts with CAA.</p> answering member printed Baroness Buscombe attachment 1 file name HL636 - Associated Guidance Document CAP 1484 (March 2017).pdf title Associated Guidance Document CAP 1484 2 file name HL636 - HSE CAA Memorandum of Understanding.pdf title HSE CAA Memorandum of Understanding question first answered 18/07/2017 13:18:23 answering member 3349 label Biography information for Baroness Buscombe
tabling member	1861 label Biography information for The Countess of Mar

749952

registered interest
date	10/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Kingston Hospital
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government who were the experts the National Institute for Health and Clinical Excellence consulted in their recent review of Clinical Guideline CG 53 for chronic fatigue syndrome and myalgic encephalomyelitis: diagnosis and management.
tabling member printed	The Countess of Mar
uin	HL637
answer	answer is ministerial correction date of answer 19/07/2017 answer text <p>The National Institute for Health and Care Excellence (NICE) routinely consults a range of topic experts as part of its surveillance review process. NICE is currently consulting on a review proposal for its clinical guideline on the diagnosis and management of chronic fatigue syndrome and myalgic encephalomyelitis. NICE does not routinely publish the names of topic experts as they are not part of the decision making process for the surveillance review.</p><p><strong> </strong></p> answering member printed Lord O'Shaughnessy question first answered 19/07/2017 11:03:41 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1861 label Biography information for The Countess of Mar

747427

registered interest
date	03/07/2017
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government why products are not required to carry labels which indicate exactly what flame retardant materials they contain, including those materials which were permitted at the time of production but have since been banned, in order to (1) enable people to avoid those products if they so wish, and (2) ensure that people are aware that it may not be possible to recycle or sell on those products.
tabling member printed	The Countess of Mar
uin	HL391
answer	answer is ministerial correction date of answer 14/07/2017 answer text <p>Product safety legislation requires products to be safe when they are placed on the market. It does not specifically require products to be labelled with information about fire retardant material used in the products.</p><p>The Government is currently reviewing the Furniture and Furnishings (Fire) (Safety) Regulations 1988. One of the proposals under consideration is specific labelling to show the presence of fire retardant chemicals to help inform consumers and to aid consumer choice. A consultation on this issue was held in late 2016. The responses to the consultation will help to inform our decisions on this question and will be included in the Government response, to be issued in due course.</p> answering member printed Lord Prior of Brampton question first answered 14/07/2017 13:49:38 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	1861 label Biography information for The Countess of Mar

746633

registered interest
date	29/06/2017
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government what measures they are taking to ensure that flame retardant materials used in homes, offices and public spaces both (1) prevent fires, and (2) are non-toxic, (a) in normal use, (b) during fires, and (c) for disposal or recycling at the end of life of items, such as furniture, foam mattresses, electronic goods and building insulation which contain such materials.
tabling member printed	The Countess of Mar
uin	HL264
answer	answer is ministerial correction date of answer 13/07/2017 answer text <p>Public safety is a priority for Government. There are a range of measures in place across a number of Government departments to ensure the effectiveness and safety of flame retardant materials.</p><p> </p><p>The Department for Business, Energy and Industrial Strategy is responsible for product safety legislation, which requires products to be safe when they are placed on the market.</p><p> </p><p>The Department for the Environment, Food and Rural Affairs has responsibility for ensuring the safety of chemicals, including those used as flame retardants.</p><p> </p><p>The Health and Safety Executive oversees the EU regulations concerning the Registration, Evaluation, Authorisation and restriction of Chemicals (known as REACH). This has several aims, including providing a high level of protection of human health and the environment from the use of chemicals.</p><p> </p><p>Lead responsibility for the safety and effectiveness of flame retardant chemicals will rest with the Department responsible for any legislation specifying their usage.</p> answering member printed Baroness Williams of Trafford grouped question UIN HL265 question first answered 13/07/2017 14:40:39 answering member 4311 label Biography information for Baroness Williams of Trafford
tabling member	1861 label Biography information for The Countess of Mar

746634

registered interest
date	29/06/2017
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government whether there is any one Government department charged with ensuring that all fire retardant materials are safe and effective at all times.
tabling member printed	The Countess of Mar
uin	HL265
answer	answer is ministerial correction date of answer 13/07/2017 answer text <p>Public safety is a priority for Government. There are a range of measures in place across a number of Government departments to ensure the effectiveness and safety of flame retardant materials.</p><p> </p><p>The Department for Business, Energy and Industrial Strategy is responsible for product safety legislation, which requires products to be safe when they are placed on the market.</p><p> </p><p>The Department for the Environment, Food and Rural Affairs has responsibility for ensuring the safety of chemicals, including those used as flame retardants.</p><p> </p><p>The Health and Safety Executive oversees the EU regulations concerning the Registration, Evaluation, Authorisation and restriction of Chemicals (known as REACH). This has several aims, including providing a high level of protection of human health and the environment from the use of chemicals.</p><p> </p><p>Lead responsibility for the safety and effectiveness of flame retardant chemicals will rest with the Department responsible for any legislation specifying their usage.</p> answering member printed Baroness Williams of Trafford grouped question UIN HL264 question first answered 13/07/2017 14:40:39 answering member 4311 label Biography information for Baroness Williams of Trafford
tabling member	1861 label Biography information for The Countess of Mar

746643

registered interest
date	29/06/2017
answering body	Attorney General
answering dept id	88
answering dept short name	Attorney General
answering dept sort name	Attorney General
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government how many cases of (1) Munchausen's syndrome by proxy, and (2) fabricated or induced illness, have been prosecuted against parents of children diagnosed with myalgic encephalomyelitis or chronic fatigue syndrome in each year since 2010 for which figures are available; how many of those cases were successful; how many were withdrawn; and how many resulted in an acquittal.
tabling member printed	The Countess of Mar
uin	HL274
answer	answer is ministerial correction date of answer 10/07/2017 answer text <p>Munchausen's syndrome by proxy and fabricated or induced illness are not of themselves criminal offences so cannot be prosecuted as such. They may, however, be of relevance to criminal offences which can be prosecuted.</p><p>The Crown Prosecution Service (CPS) does not maintain a central record of prosecutions where Munchausen’s syndrome by proxy or fabricated or induced illnesses may have been relevant. Such information could only be obtained through a manual search of records which would incur disproportionate cost.</p> answering member printed Lord Keen of Elie question first answered 10/07/2017 14:14:57 answering member 4538 label Biography information for Lord Keen of Elie
tabling member	1861 label Biography information for The Countess of Mar

746644

registered interest
date	29/06/2017
answering body	Ministry of Justice
answering dept id	54
answering dept short name	Justice
answering dept sort name	Justice
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government what is the average total cost to (1) local authorities, (2) health authorities, (3) local education authorities, and (4) the courts, of prosecuting an unfounded case of Munchausen's syndrome by proxy.
tabling member printed	The Countess of Mar
uin	HL275
answer	answer is ministerial correction date of answer 13/07/2017 answer text <p>The information requested is not held.</p> answering member printed Lord Keen of Elie question first answered 13/07/2017 15:40:06 answering member 4538 label Biography information for Lord Keen of Elie
tabling member	1861 label Biography information for The Countess of Mar

732744

registered interest
date	26/06/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government, further to the Written Answer by the Parliamentary Under-Secretary of State, Department of Health, on 24 April (HC70973), when and how the Commission on Human Medicines "thoroughly review the data" on human papilloma virus (HPV) vaccine adverse reactions.
tabling member printed	The Countess of Mar
uin	HL182
answer	answer is ministerial correction date of answer 04/07/2017 answer text <p>The Commission on Human Medicines (CHM) is the Government’s scientific advisory committee, from which the Medicines and Healthcare products Regulatory Agency (MHRA) seeks independent scientific advice.</p><p> </p><p>The CHM considered a thorough review of the safety of human papillomavirus (HPV) vaccine at its meeting on 16 July 2015. Prior to 2015, the CHM considered reviews of HPV vaccine at meetings in September 2012, September 2010, September 2009, June 2009 and February 2009. These reviews included evaluation of United Kingdom Yellow Card reports, analysis of data from the Clinical Practice Research Datalink (CPRD), published safety studies and safety data from other countries.</p><p>Most recently, the CHM considered the safety of HPV vaccine at its meeting on 15 October 2015. At this meeting, the MHRA sought advice from the CHM on the (Co)-Rapporteurs’ assessment reports prepared for the European Medicines Agency (EMA) review into reports of postural orthostatic tachycardia syndrome and complex regional pain syndrome following HPV vaccine, in order to inform the UK position in the review.</p><p><strong> </strong>As with all vaccines and medicines, the safety of HPV vaccine remains under continual review by the MHRA.</p> answering member printed Lord O'Shaughnessy question first answered 04/07/2017 16:04:46 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1861 label Biography information for The Countess of Mar